Brian is a trial lawyer focusing primarily on patent litigation, often defending companies accused of patent infringement. His work spans diverse technology areas, such as pharmaceuticals, medical devices, diagnostic tools, and DNA sequencing techniques. He has also represented makers of ultracapacitors, video compression techniques, and wireless technology.
Brian has successfully tried cases in U.S. district courts and successfully argued appeals before the U.S. Court of Appeals for the Federal Circuit. His trial experience includes obtaining a jury verdict of non–infringement for a client sued by a rival for over $100 million, and a bench trial involving a drug with annual sales over $4 billion.
Brian is a member of the American Intellectual Property Law Association, Federal Circuit Bar Association, and American Bar Association. He is chair of the board of directors of the Japan Society of San Diego and Tijuana, and past president of the board of directors of the Legal Aid Society of San Diego.
In law school, he served as an associate editor of the University of Illinois Law Review and as the first managing editor of the University of Illinois Journal of Law, Technology & Policy.
Chugai Pharmaceutical Co., Ltd. v. Alexion Pharmaceuticals, Inc.(District of Delaware) Representing Chugai Pharmaceutical as the plaintiff patent owner in litigation involving Chugai’s recycling antibody technology. Trial is scheduled for 2020.
Baxalta Incorporated v. Genentech, Inc. and Chugai Pharmaceutical Co., Ltd.(District of Delaware) Representing Chugai Pharmaceuticals in litigation involving Chugai’s prescription hemophilia medicine, Hemlibra®. Helped devise strategy to defeat a preliminary injunction motion and to get Chugai dismissed from the case, which is currently on appeal.
DNA Genotek v. Ancestry.com DNA (District of Delaware) Represented DNA Genotek in litigation asserting patent involving DNA sample collection devices. Obtained an eight–figure settlement and ongoing royalty following favorable IPR and claim construction proceedings.
Allergan Inc. v. Alcon Laboratories and Sandoz Inc.(Eastern District of Texas) Represented Alcon and Sandoz at trial in Hatch–Waxman litigation involving glaucoma medication. Assumed case from prior counsel who lost first trial. Devised a new regulatory strategy that resulted in noninfringement verdict after convincing court to order a new trial.
Round Rock Research v. Dole Food Co. (District of Delaware) Represented Dole in a patent infringement case involving RFID technology. Successfully argued motion to stay case pending reexamination before the PTO and then settled case on favorable terms.
Abbott Laboratories v. DexCom(District of Delaware) Represented DexCom in a patent infringement case involving continuous blood glucose monitoring systems. Defeated preliminary injunction efforts, allowing client to become first to launch product.
NessCap Co. Ltd. v. Maxwell Technologies, Inc.(District of Delaware) Represented Maxwell in a case in which both parties asserted patents against each other. Obtained rare transfer out of the District of Delaware when both plaintiff and defendant were Delaware corporations. Maxwell ultimately obtained a preliminary injunction for infringement of its patents. Led appeal team to preserve the injunction, settling on favorable terms on the eve of the Federal Circuit argument.
Allergan Inc. v. Sandoz Inc.(District of Delaware) Represented accused infringer and was part of the team that obtained a verdict of patent invalidity for obviousness. Argued and won appeal before U.S. Court of Appeals for the Federal Circuit.
©1996-2019 Morrison & Foerster LLP. All rights reserved.